ToolGen Inc.
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, … Read more
ToolGen Inc. (199800) - Total Liabilities
Latest total liabilities as of September 2025: ₩14.88 Billion KRW
Based on the latest financial reports, ToolGen Inc. (199800) has total liabilities worth ₩14.88 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ToolGen Inc. - Total Liabilities Trend (2016–2024)
This chart illustrates how ToolGen Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ToolGen Inc. Competitors by Total Liabilities
The table below lists competitors of ToolGen Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥1.62 Billion |
|
BYBON Group Co Ltd Class A
SHE:300736
|
China | CN¥48.15 Million |
|
BCPG Public Company Limited
BK:BCPG
|
Thailand | ฿29.15 Billion |
|
Akcansa Cimento Sanayi ve Ticaret AS
IS:AKCNS
|
Turkey | TL9.02 Billion |
|
Inzone Group Co Ltd
SHG:600858
|
China | CN¥8.77 Billion |
|
Medistim ASA
OL:MEDI
|
Norway | Nkr151.23 Million |
|
Hefei Gocom Information Technology Co Ltd
SHG:688367
|
China | CN¥144.72 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down ToolGen Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ToolGen Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ToolGen Inc. (2016–2024)
The table below shows the annual total liabilities of ToolGen Inc. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩17.04 Billion | -73.10% |
| 2023-12-31 | ₩63.36 Billion | +1176.94% |
| 2022-12-31 | ₩4.96 Billion | +68.03% |
| 2021-12-31 | ₩2.95 Billion | +17.20% |
| 2020-12-31 | ₩2.52 Billion | -18.61% |
| 2019-12-31 | ₩3.10 Billion | +76.56% |
| 2018-12-31 | ₩1.75 Billion | -19.31% |
| 2017-12-31 | ₩2.17 Billion | +56.02% |
| 2016-12-31 | ₩1.39 Billion | -- |